chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient developed hives almost all over body, started on torso, but involved  feet, forehead, buttocks.
Wheezing. Prednisone for 3 days. Shortness of breath. Albuterol 3 times a day for 3 days.
On 10/07/17 around 5 am patient had a febrile seizure. His temperature read 104 immediately following his seizure. TYNELOL and MOTRIN were alternated throughout the day to keep his fever down. He was very drowsy and very fussy. He fell asleep on the floor and woke up approximately 30 minutes later. I picked him up and held him in my lap when he had another febrile seizure around 1:00pm. His temperature read 103.5 immediately following the seizure.
Syncope- pale, nauseous, initially disoriented when regained consciousness, sweating. Patient was taken to ED. Escorted out by EMS.
ADACEL tdap (L) deltoid 11/16/11 - increased pain redness to site starting 11/18/11. ER eval 11/20/11 -> Dx cellulitis 5 1/2 cm x 9 cm (at widest width) to (L) UE. 11/20/11 started oral antibiotics (thinks it is cephalexin 500 mg po 4 x daily) - Pt to verify abx given by ER.
Healthcare Professional administered the vaccine without realizing that it  has expired 35 minutes prior. The error was noted after the patient let.  Per Dr there is no  harm to the patient  &  no treatment is indicated. Healthcare Professional was educated about expiration, documentation of vaccines.
Patient was accompanied by her son for translation, who also completed her paperwork for the Pfizer booster.  Pharmacist asked patient's son for the patient's vaccination card, to which the patient's son replied that his father was carrying the card and would return to the pharmacist after using the restroom.  Patient's son assured the pharmacist that the patient had last received their Pfizer second dose at least 6 months prior.  Patient's Eligiblity Attestation Form was also completed with a checkmark stating so.  Pharmacist proceeded with giving the patient the shot while waiting for her husband to arrive with the vaccination card so that pharmacist could fill it out.  When patient's husband arrived, he handed over her vaccination card, which stated that the second Pfizer dose had been given on 4/13/21.  Pharmacist realized that the patient had received her booster shot a few days early (180 days, or 6 months, from 4/13/21 would be 10/10/2021).
having heart problems from the COVID-19 Shot; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CARDIAC DISORDER (non-serious), outcome "not recovered", described as "having heart problems from the COVID-19 Shot". The event "having heart problems from the covid-19 shot" required physician office visit.  Additional information: Question: Caller wanted to contact the CICP after he reported with Pfizer on 12Jul2023, reportum, that he's been having heart problems from the COVID-19 Shot. Caller only added that his doctor hasn't been able to do anything for him and can't find the problem. No further details were shared as caller wanted to be transferred to the department.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Very easy pregnancy. Due date June 6th.  No prior issues   After given the shot digestive issues began Diarrhea 3/ daily with accompanying stomach pain   Noticed eating cereals/oatmeal?s made symptoms worse   5lbs birth weight
urticaria; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (urticaria) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2021, the patient experienced URTICARIA (urticaria). At the time of the report, URTICARIA (urticaria) had not resolved.            Patient had urticaria since approx 10 days post booster shot 03-Dec-2021. No concomitant medications were provided. No treatment medications were provided
This spontaneous report as received from a pharmacist refers to a patient of unknown age. On 14-FEB-2013 the patient was vaccinated with an expired dose ZOSTAVAX 19400 PFU, lot # 672428/1599AA, expiry date 13-JAN-2013, 0.65 ml, subcutaneous. No adverse effect reported. Additional information has been requested. This report is linked by same reporter link to case # 1309USA003230, 1309USA003219, and 1309USA003211.
Pt.states that her left arm started hurting to the point she couldn't move it. The night of injection she 'felt like she had been hit by a truck' she ached all over had fever, chills sweating.  There was tenderness at site, with shooting pain up into right side of neck. Pt took Motrin and bed rest.
Ongoing dizziness, fog brain, weakness, fatigue, poor appetite, loss 7 pounds, heartburn, increase of anxiety, no motivation to do the things he once enjoyed
Symptoms were first noticed the following day of the vaccination at at 6 AM. They were chills, hands and feet being extremely and unusually cold, fatigue, body aches and soreness at point of vaccination. Body temperature increased but not to above 98.6.
SLIGHT REDNESS IN PM ON 10/19/2010 PER MOTHER OF CHILD. WOKE UP 10/20/2010 ARM RED WITH STREAK GOING DOWN ARM APPROX 32 FINGER WIDTHS PER MOM. CHILD AT SCHOOL. MOTHER TO CALL PEDIATRICIAN OFFICE AND TAKE CHILD FOR VISIT.
Tachycardia within 3 hours of 3rd booster dose of 115 bpm for 36 hours; at 100 bpm at 48 hours-60 hours (still unresolved).; gastro discomfort; Fever; chills; joint aches; muscle aches; the third dose; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient (non-pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), the third dose via unspecified route of administration in right arm on 16Oct2021 at 09:30 AM (lot number: Pfizer FE3590) as single dose for COVID-19 immunization. The relevant medical history included birth control from unspecified date. Concomitant medications included esomeprazole magnesium (NEXIUM) from unspecified date for unspecified indication; ethinylestradiol, norethisterone (NECON) from unspecified date for birth control. The patient previously received BNT162B2, the first dose on 09Apr2021 (Pfizer BioNTech, lot number: EW0150, administration time: 11:00 AM, dose number: 1, vaccine location: Left arm) and the second dose on 29Apr2021 (Pfizer Biontech, lot number: Pfizer ER8731, administration time: 10:00 AM, dose number: 2, vaccine location: Left arm), both at the age of 42 years old for Covid-19 Immunization. The patient experienced tachycardia within 3 hours (as reported) of 3rd booster dose of 115 bpm for 36 hours; at 100 bpm at 48 hours-60 hours (still unresolved). Fever, chills, gastro discomfort, muscle aches and joint aches 12 hours-36 hours after booster. These adverse events were started on 16Oct2021 at 09:30 PM. No treatment received for these events. No covid prior vaccination. These events resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab test included heart rate showed 115 bpm for 36 hours on 16Oct2021 and 100 bpm at 48 hours-60 hours on an unspecified date in Oct2021; Covid-19 test with unknown results on an unspecified date. The outcome of the event "Tachycardia within 3 hours of 3rd booster dose of 115 bpm for 36 hours; at 100 bpm at 48 hours-60 hours (still unresolved)" was not recovered, for event "the third dose" was unknown, while the other events were recovered with sequel on an unspecified date in Oct2021.  Follow-up attempts are completed. No further information is expected.
Feb 07 has left leg pain(sensations), thought maybe a pinched nerve, pained worsened.  8/07 pain more severe,  went to Dr for blood work, MRI, to rule out Arthritis.  Leg feels, weak, heavy and numb.  Experiencing severe headaches.  12/07 sensations now in Left arm.  Pain continues.  2/08 more blood work, comes back fine.  Unable to continue select Volleyball.  Had more MRI's to rule out pinched nerve.  Experiencing muscle spasms.  3/08 brain MRI, experiencing back pain(more severe than usual).  5/08 visited hospital Neurology.  Had another brain MRI, came back good.  6/08 had nerve study conducted at Med. Center.  No abnormal result found.  9/15/08 MR received from PCP 10/5/06-8/13/08. Seen 8/7/07 for WCC with chronic knee pain and 8/25/07 with toe fx 2' injury-hematoma under nail. Seen 10/10/07 for h/a, nausea & dizziness 2' ball injury. C/o hypersensitive hearing. Assessment:  Hyperacousis/H/A 2' to contracorp injury. O/V 1/9/08 with flu-like illness. Seen 2/7/08 for back pain, vag d/c and anxiety-with occ SOB, tachycardia. Seen 2/26/08 with c/i impaired sllep 2' to pain.  On PE DTRs R>L. Assessment:  Radiculopathy.  Hyperhidrosis. OV 8/1/08 for neck pain, arm pain low back pain. Also scalp tenderness, R numbness.  Assessment:  Myalgia/ muscle cramps. OV 8/13/08 for constipation. 9/30/08 Neuro and Neurosurg consults received dated 5/6/08 and 5/30/08. Referred for increasing bilateral leg and L arm  numbness and paresthesias. Neuro exam (+) for decreased sensation L leg, otherwise WNL.   Referred to neuro. PE (+) for anxiety, sweaty palms, decreased vibration sensation lower extremities.  Referred for EMG/NCS-reported as normal by PCP. Assessment: ? motor/sensory neuropathy, ? mild myopathy, ? psychogenic.
I experienced a reaction at the injection site for my second Moderna dose. It started with redness to my arm. My symptoms at the vaccine site was warm to the touch on area and it was very itchy. I felt warm to touch but never had a fever, felt my body warm at times. This lasted for about two weeks and came back few weeks later then it went away but not as constant as before. I also can say that on my first dose I experienced some redness at the injection site. I went to see my doctor who prescribed a topical cream to apply to the injection site.
Fever up to 102.7 (with taking Tylenol every 4 hours) nausea, headaches, extremely bad body aches to where I could barely get out of bed, fatigue. Fever stayed that high for about 20 hours, then 100 temp the next day  and symptoms less severe, the 3rd day fever was 99 and less symptoms. I sought no further care from health provider and by 4th day back to normal.
COVID (+) fully vaccinated employee, off work for quarantine, symptomatic sniffles and congestion, body aches, fever & chills improved with Tylenol, diarrhea, headache, fatigue
Shot was very painful; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by patient himself/herself. The age group was not reported but was captured as an adult as per vaccine indication.  The age at vaccination was not reported. The patient stated shingles shot was very painful. The follow-up would not possible as no contact details were available.
Systemic: Headache, Systemic: IRREGULAR HEARTBEAT (HAS HISTORY OF AFIB), COMPLAINED OF BEING HOT; symptoms lasted 0 days
Patient became dizzy and felt that throat was becoming itchy and tight about 1-2 minutes after injection. Provided patient with 25 mg of diphenhydramine and a bottle of water and observed. After ~ 20 minutes patient left on her own.
Symptoms: Facial swelling, nausea, vomiting, headache, dizziness, and low blood pressure -Occurred at 11 PM on 06 Jan 2021 Treatment: benadryl, solu-medrol, epinephrine, prednisone at ER
Patient ID:  MRN:   Name:   Age: 77 y.o.  Birthday:    Admit Date: 8/16/2022  8:55 PM  Discharge Date: 8/24/2022     Unit:   Admitting Physician:    Discharge Physician: MD     Discharge Diagnosis:  Principal Problem:    SOB (shortness of breath)  Active Problems:    Paroxysmal atrial fibrillation    Supratherapeutic INR    SVT (supraventricular tachycardia)    Elevated troponin    Acute combined systolic (congestive) and diastolic (congestive) heart failure    Positive cardiac stress test    AKI (acute kidney injury)    Gross hematuria    Hyperlipidemia    HTN (hypertension)    Type 2 diabetes mellitus with hyperglycemia, without long-term current use of insulin              Hospital Course: Patient is a 77 y.o. male admitted with sob / covid 19 / paroxysmal afib / acute on chronic systolic and diastolic hf / uti / trop elevation determined to be type 2 mi. Seen by cards. Also concern for svt nonsustained. lhc performed. Moderate cad, no intervention. Tee / tte performed, ef 30-35%. Cardioverted to nsr. Started on amio / cardiac meds. aki developed after diuresis. Improving back to baseline. Restarting small dose acei. Will delay aldactone, but chf meds need titrating up outpatient with close monitoring of renal function. Uti grew e faecalis, started on amoxicillin and will finish this op. Not treated for covid 19 as symptoms unrelated to this. Nephrology assisted with case given aki and need for contrast. Urology also assisted, give gross hematuria briefly. Foley left in place. Removal op with urology. Life vest prior to dc. Close f/u op     No new Assessment & Plan notes have been filed under this hospital service since the last note was generated.  Service: Hospitalist                 Physical Exam on the Date of Discharge:  Vitals: Blood pressure 100/63, pulse 107, temperature 97.7 °F (36.5 °C), temperature source Oral, resp. rate 14, height 6' (182.9 cm), weight 80.2 kg (176 lb 11.2 oz), SpO2 99 %.   General Appearance: alert, NAD  Lungs:  normal effort  Heart: S1 S2 heard            Consults:    IP CONSULT TO CARDIOLOGY  IP CONSULT TO HEART FAILURE NURSE  IP CONSULT TO DIETARY  IP CONSULT TO CARDIAC REHAB  IP CONSULT TO SOCIAL WORK  IP CONSULT TO CARDIOLOGY  IP CONSULT TO UROLOGY              Disposition:  home     Discharge Condition:  fair
Information has been received from a registered nurse concerning a 15 month old female with no  known allergies, birth defects or pre-existing medical conditions who on 10/22/02 was vaccinated with a dose of MMR II given SC in the left leg (641881/0772M). On 10/31/02 (previously reported as approximately 10/22/02) the pt developed a scattered papular rash on her abdomen and a high temperature. On 11/1/02 the pt was seen in her physician's office. The pt was treated with Advil and her fever responded to it. Hospitalization was not required. Subsequently, the pt recovered. The pt sought unspecified medical attention. No further info is available.
Uncontrollable diarrhea; Fatigue; Muscle soreness  all over body; Sweating; Headache; This is a spontaneous report from a contactable consumer, the patient. A 34 years old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6207), via an unspecified route of administration in the right arm on 18Mar2021 at 18:45 (at the age of 34-year-old), as a single dose for COVID-19 immunisation. The patient medical history included type 2 diabetes. The patient did not have allergies to medications, food, or other products. Concomitant medications included Vitamin D2 (MANUFACTURER UNKNOWN), blisovi 24 Fe (MANUFACTURER UNKNOWN) for an unknown indication from an unspecified date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 19Mar2021 at 10:00, the patient experienced uncontrollable diarrhoea, fatigue, muscle soreness all over body, sweating and headache. The patient did not receive any treatment for adverse event. The clinical outcome of uncontrollable diarrhoea, fatigue, muscle soreness all over body, sweating and headache was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Outbreak, looked like hives, on her torso and stomach area, after the first vaccine:; Chills, after first and second vaccine; Injection site sore after first and second vaccine; Arm was numb, tingley and painful from the shoulder to the fingertips, after the first and second vaccine; Arm was numb, tingley and painful from the shoulder to the fingertips, after the first and second vaccine; Arm was numb, tingley and painful from the shoulder to the fingertips, after the first and second vaccine; This is a spontaneous report received from a contactable consumer (patient). A 76-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6204, Expiration date was not reported), via an unspecified route of administration on 03Mar2021 14:00 as 1st dose, single dose for COVID-19 immunisation. Medical history and concomitant medications were reported as none. On 03Mar2021, the patient experienced outbreak, looked like hives, on her torso and stomach area, with sequelae after the first dose, chills after first and second vaccine, injection site sore after first and second vaccine, Arm was numb, tingley and painful from the shoulder to the fingertips, after the first and second vaccine (Patient visited office). she would like to know about percentages in age groups who have experienced any numbness and tingling, and if there are any correlation with developing blood clots of this, and also, she wanted to know if she needs further medical attention and to prevent a serious outcome. The outcome of the event was recovered for urticaria on 21Mar2021, the outcome of chills was unknown. Vaccination site pain, Hypoaesthesia Paraesthesia was not recovered.  No follow-up attempts are needed. No further information is expected.
Guillain-Barre syndrome beginning about 1mo after receiving J&J COVID vaccination leading to a chronic dymelinating polyneuropathy with progressive bilateral lower then upper extremity weakness and paresthesias, dysphagia, aspiration pneumonia and repeated aspiration events, and, ultimately, her death on 01/15/2022.
according to surgeon pt had sterile abscess;there was no growth from cult;father stated was size of hen egg;whole leg swollen red, hot to touch; was seen by MD;
Symptoms started on 3/17/2021 around 9am- nausea 3/17/2021 at 1 Pm, more symptoms nausea, chills, aches, head ache.  On 3/17/2021 fever started as well at 5 pm fever was about 103.4
Left hand shaking. Had unusual sweating previous to vaccine. Difficulty sleeping, took as need extra dose of Gabba petin and fell asleep.
PATIENT RECIEVED SECOND DOSE 98 DAYS AFTER FIRST DOSE
4x3 local rxn, warm to touch;no pain;no fever;possible cellulitis;
SHINGLES; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of HERPES ZOSTER (SHINGLES) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (SHINGLES). At the time of the report, HERPES ZOSTER (SHINGLES) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment details not reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jan-2021: No Follow up document attached
Brain hemorrhage; This is a spontaneous report from a contactable consumer (patient). This 56-year-old male patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number En6200) at single dose on 06Apr2021 13:00 via an unknown route in left arm for Covid-19 immunization. Medical history included hospitalization and vaccine received during existing hospitalization. Prior to vaccination, the patient was not diagnosed with COVID-19. Patient had no known allergies. Concomitant drug was not provided.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced brain hemorrhage on an unknown date in Apr2021. The event resulted in emergency room/department or urgent care, prolongation of existing hospitalization, disability or permanent damage. The report was reported as serious with seriousness criteria of prolonged hospitalization (hospitalization days were 37 days) and disabling. Outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected.
No adverse event; 1st dose administered on 22Mar2021 and 2nd dose administered on 10Apr2021; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose administered on 22Mar2021 and 2nd dose administered on 10Apr2021) and NO ADVERSE EVENT (No adverse event) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 048B21A) for COVID-19 vaccination.     The patient had not ever diagnosed with COVID positve test.  The patient's past medical history included Ex-smoker (Former smoker) in 2012. Concurrent medical conditions included Seasonal allergy, Drug allergy (does not feel well when given Sudafed), Drug allergy (does not feel well when given Codeine), COPD (slight COPD), Emphysema (slight emphysema), Osteoporosis and Depression. Concomitant products included PAROXETINE HYDROCHLORIDE (PAXIL [PAROXETINE HYDROCHLORIDE]) for Depression.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose administered on 22Mar2021 and 2nd dose administered on 10Apr2021). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose administered on 22Mar2021 and 2nd dose administered on 10Apr2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Computerised tomogram: patient had a regular CatScan to monitor her lungs.         No treatment medications were provided by the reporter.   This case was linked to MOD-2022-568686 (Patient Link).
blister on her arm; rash on her neck; severe allergic reaction to a booster dose; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (blister on her arm), RASH (rash on her neck) and HYPERSENSITIVITY (severe allergic reaction to a booster dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLISTER (blister on her arm), RASH (rash on her neck) and HYPERSENSITIVITY (severe allergic reaction to a booster dose). At the time of the report, BLISTER (blister on her arm), RASH (rash on her neck) and HYPERSENSITIVITY (severe allergic reaction to a booster dose) outcome was unknown.            No relevant concomitant medications were reported. Treatment information was unknown.  The patient seemed distressed and hung up.   Reporter did not allow further contact